InvestorsHub Logo
Followers 1
Posts 183
Boards Moderated 0
Alias Born 07/30/2014

Re: Xrouter post# 26543

Saturday, 11/29/2014 10:12:55 AM

Saturday, November 29, 2014 10:12:55 AM

Post# of 48316
If oncs could indeed turn 60-80 percent of the non responding population into responders then a 15-20 dollar buyout is not out of the question. Given that pd-1 is estimated to generate 35 billion in the next 5 years and Merck would be able to take a majority of the patient population and market share if oncs can deliver the results that they believe they can. Merck would be leaps and bounds ahead of their completion in response rates and lower SAE's. I don't think that a buyout offer will come until end of phase 3 and fda appoval however. So probally 3 years from now. Just imagine if everything went according to plan! Punit's shares alone would be worth close to 90 mil at 20 dollars a share, and I will be 33 and retired. I think that the prieces were being lined up right when dr. Pierce came to oncs. Now we have another member from Merck, our new in house attorney. Only time will tell.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCSQ News